Market Overview The global neuroendocrine carcinoma treatment market is experiencing growth driven by somatostatin analog therapy expansion, molecular-targeted agents advancing, and improved diagnostic capabilities enabling earlier treatment identification. The global NEC treatment market is projected to exceed USD 6 billion through 2030, fueled by neuroendocrine cancer prevalence,...